Nonproteolytic, Avirulent Bacillus anthracis as a Live Vaccine

AUTOR(ES)

Fubra, Ernest S.

RESUMO

Fubra, Ernest S. (Federal Department of Veterinary Research, Vom, Nigeria). Nonproteolytic, avirulent Bacillus anthracis as a live vaccine. J. Bacteriol. 91:930–933. 1966.—A nonproteolytic mutant, derived from the Sterne strain of Bacillus anthracis by exposure to ultraviolet radiation, was used for vaccination of guinea pigs. Vaccine prepared from the parent Sterne strain was used in comparable immunization procedure. Comparison of the protection induced by the two vaccines showed that use of the nonproteolytic mutant was from 10 to 1,000 times as effective as the Sterne strain.

Documentos Relacionados

• Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig.
• Osteosynthesis-Associated Bone Infection Caused by a Nonproteolytic, Nontoxigenic Clostridium botulinum-Like Strain
• A live avirulent mutant Legionella pneumophila vaccine induces protective immunity against lethal aerosol challenge.
• Fermentation, Purification, and Characterization of Protective Antigen from a Recombinant, Avirulent Strain of Bacillus anthracis
• A Live Recombinant Avirulent Oral Salmonella Vaccine Expressing Pneumococcal Surface Protein A Induces Protective Responses against Streptococcus pneumoniae